Navigation Links
Phase 3 Topical Drug for Raynaud's Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
Date:12/13/2012

tary topical delivery system in late-stage clinical trials targeting infectious and inflammatory skin diseases and conditions. The Company's major efforts have been focused on projects targeting Raynaud's phenomenon, nail psoriasis and actinic keratosis. In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the 'Safe Harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the Company's current expectation or forecasts of future events. MediQuest's performance and financial results could differ materially from those reflected in these forward-looking statements due to the decisions of regulatory authorities, ability to implement its commercial plans, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries generally. For a discussion of these and other risks and uncertainties that may affect the forward-looking statements please contact the Company. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. MediQuest undertakes no obligation to update publicly any forward-looking statement
www.mqti.com

Contact information
Joseph K. Piper
Managing Director, Point B Capital
jpiper@pointbcap.com
206-577-7223

Media Contact: Siavash Forootan MediQuest Therapeutics, 215-238-8881, sforootan@numodacapital.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediQuest Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
2. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
3. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
4. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
5. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
6. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
7. uniQure Initiates Phase I in Acute Intermittent Porphyria
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 At the 2015 ... will present findings that a first-of-its-kind smartphone test ... accuracy, which could reduce the prevalence of this ... easier and cheaper. Most people with ... infection often causes no symptoms, but if left ...
(Date:7/29/2015)... DUBLIN , July 27, 2015 ... the addition of the "Pharmaceutical Packaging Market by ... by Region(North America, Europe, Asia-Pacific, RoW) - Forecasts to ... global pharmaceutical packaging market demand, by value is estimated ... The pharmaceutical packaging market is anticipated to show a ...
(Date:7/29/2015)... RATON, Fla. , July 29, 2015 /PRNewswire/ ... launch of Azelastine HCl Nasal Solution, 0.1%. The U.S. ... Abbreviated New Drug Application (ANDA), which is AB ... Pharmaceuticals. Azelastine hydrochloride nasal solution (nasal spray) is ... June 2015 IMS Health sales data.  Azelastine HCl ...
Breaking Medicine Technology:First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3
(Date:7/29/2015)... ... 29, 2015 , ... The healthcare analytics market is categorized ... Factors such as the rising pressure to curb healthcare costs, big data in ... capital investments are driving market growth. Check 149 data tables & 57 figures ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... anticipating testing regulations imposed by the FDA for nicotine laced liquid products. Their ... electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as ...
(Date:7/29/2015)... ... ... Orthopedic surgeons at Lourdes Medical Center of Burlington County are the first in ... to treat a common source of shoulder pain and disability. , The minimally ... could allow for faster healing and a decreased chance of future tendon tearing. ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for a health center to ... of care. One that is very hands on and resident oriented, and one to ... “She’s bringing great passion and energy, as well as a strong commitment to helping ...
Breaking Medicine News(10 mins):Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3
... 10, 2008 IPC,The Hospitalist Company, Inc. (Nasdaq: ... the delivery of hospitalist medicine services,announced today that it ... 31, 2008 on Wednesday, May 14, 2008, after the ... results will begin at 5:00 p.m. ET,(2:00 p.m. PT) ...
... available for comment, PHILADELPHIA, April 10 The ... letter on,Thursday, calling on the major Democratic candidates campaigning ... healthcare access and,lower costs in SB 1137, HB 2098 ... 10, 2008, Dear Senator Clinton and Senator Obama:, ...
... Why are you so disappointed?, CHICAGO, April 10 ... It has to do with changing expectations., Businesses ... an attitude,that says, "We need a web presence. Now!" We ... the web!, This realization is usually followed by weeks ...
... Meets Number One Consumer Request, PLANO, Texas, April ... the launch of Pinch of Salt, a,low-sodium version of ... Tostitos tortilla chips, Fritos corn chips and Ruffles potato ... to begin with,-- for instance Lay,s Classic potato chips ...
... BENSALEM, Pa., April 9 Law Offices of ... against Merck & Co., Inc.,("Merck" or the "Company")(NYSE: ... and Security Plan (the "Plan") imprudently invested in,Merck ... fiduciary,duties to the Plan,s participants in violation of ...
... ANGELES, April 9 The Los Angeles ... children hospitalized for,cancer and other serious illnesses, ... a half block from its original Fountain ... low cost, often free, lodging to,75-families per ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results 2Health News:Open Letter to Presidential Candidates on State Health Care Reform 2Health News:So ... You Went and Got a Pretty Web Site. 2Health News:Frito-Lay Launches Low Sodium Versions of its Top Selling Snack Chips 2Health News:Los Angeles Ronald McDonald House Doubles Lodging Capacity for Families of Hospitalized Children 2Health News:Los Angeles Ronald McDonald House Doubles Lodging Capacity for Families of Hospitalized Children 3
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
On the wards, on rounds, or at the bedside, clinicians can instantly access authoritative, up-to-date, practical guidelines for the immediate and long-term medical and surgical management of all card...
The perfect quick consult for the busy cardiologist, The Ultimate Echo Guide puts the most clinically essential information in an easy access format....
Medicine Products: